Herbert Tilg

from Wikipedia, the free encyclopedia

Herbert Tilg (born August 4, 1962 in Zams ) is an Austrian internist and university professor at the Medical University of Innsbruck . He is known for his work on chronic inflammatory mechanisms and the role of inflammatory mediators ( cytokines ).

Life

Tilg graduated from the Landeck grammar school in Tyrol in 1980 and studied medicine at the Leopold-Franzens University in Innsbruck from 1980 to 1986. In Innsbruck he was trained as an internist or gastroenterologist . In 1992 he completed his training as a specialist in internal medicine. In 1988 he obtained the American State Examination in Medicine (Foreign Medical Graduate Examination in the Medical Sciences). Tilg spent research stays abroad from 1991 to 1993 at Tufts University , Boston, with Charles Dinarello , the discoverer of Interleukin-1, and in 1997 as a Clinical Fellow at Gastroenterology, Gasthuisberg, University of Leuven , Belgium. His habilitation on inflammation and liver diseases took place in 1993. In the same year he also founded his own research group, which has since dealt with inflammatory processes in gastrointestinal diseases. Prominent students such as Arthur Kaser , head of gastroenterology at Cambridge, emerged from this. From 1994–2001 Tilg was the managing senior physician at the University Clinic for Internal Medicine Innsbruck, Deputy Head of the Clinical Department for Gastroenterology and Hepatology at the University Clinic Innsbruck and from 2002 head of the Department for Internal Medicine at the State Hospital Hall in Tyrol. In 1996 Tilg acquired an additional specialist in gastroenterology and hepatology, in 1997 for oncology and in 2001 also for intensive care medicine . Tilg is currently a university professor at the Medical University of Innsbruck, where he has been director of the University Clinic for Internal Medicine I with a focus on endocrinology , gastroenterology and metabolism since 2012 .

Scientific contribution

Tilg works in the fields of chronic inflammation and the role of inflammation mediators such as cytokines in various diseases in the gastroenterology and hepatology department. The focus is on research in the field of fatty liver disease and chronic inflammatory bowel disease. Tilg is considered to be one of the pioneers in research into inflammation, immune mediators and liver disease. Most recently, his interest focused on the role of the microbiota in metabolic inflammation and associated diseases such as fatty liver disease and type 2 diabetes . He was also able to draw up internationally recognized disease hypotheses.

Tilg has been co-editor of the renowned trade journal "GUT" since 2009 and a member of numerous editorial boards of international trade journals.

honors and awards

  • 1992 Friedrich Wewalka Prize ÖGGH Prize winner
  • 1994 Anton von Eiselsberg Prize (van Swieten Society)
  • 1995 Sandoz (Novartis) Prize for Medicine
  • 2001 Aventis Prize from the University of Innsbruck
  • 2006 Falk Prize of the ÖGGH (Austrian Society for Gastroenterology and Hepatology)
  • 2009 City of Innsbruck Prize

Memberships in international associations

  • 1998–2001 member of the Scientific Committee of EASL (European Society for Liver Diseases)
  • 2005-11 Member of the Scientific Committee and Treasurer of ECCO (European Crohn's Colitis Organization)
  • Since 2012 member of the Scientific Committee of UEG (United European Gastroenterology)
  • DGIM (German Society for Internal Medicine) committee member
  • ÖGGH (Austrian Society for Gastroenterology and Hepatology)
  • ÖGIM (Austrian Society for Internal Medicine)
  • AGA (American Gastroenterology Association)

Web links

Individual evidence

  1. ^ H. Tilg, AM Diehl: Cytokines in alcoholic and nonalcoholic steatohepatitis. In: N Engl J Med. 343 (20), Nov 16, 2000, pp. 1467-1476.
  2. ^ H. Tilg, AR Moschen: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. In: Nat Rev Immunol. 6 (10), Oct 2006, pp. 772-783. Epub 2006 Sep 22.
  3. ↑ H. Tilg, A. Wilmer, W. Vogel, M. Herold, B. Nölchen, G. Judmaier, C. Huber: Serum levels of cytokines in chronic liver diseases. In: Gastroenterology. 103 (1), Jul 1992, pp. 264-274.
  4. ^ H. Tilg, AR Moschen: Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. In: Hepatology. 52 (5), Nov 2010, pp. 1836-1846. doi: 10.1002 / hep.24001 .
  5. ↑ GOOD
  6. ↑ Novartis Prize
personal data
SURNAME Tilg, Herbert
BRIEF DESCRIPTION Austrian internist
DATE OF BIRTH 4th August 1962
PLACE OF BIRTH Zams